• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

European Pharmaceutical Review Extra

The latest blogs, views and comments on the Pharma world from the leading experts in the industry…

If you would like to submit an article for the website, contact Victoria White.


nipt pregnancy

Time to address the unmet need in women’s reproductive health

Posted on: 20 September 2016 | Author: Ernest Loumaye, MD, PhD, Co-Founder & Chief Executive Officer, ObsEva

Ernest Loumaye, PhD, Co-Founder & Chief Executive Officer of ObsEva discusses the unmet need of women's reproductive health and what's in the pipeline for treatment...

antibiotics resistance

Antibiotics: resist the resistance

Posted on: 15 September 2016 | Author: Niamh Louise Marriott, Digital Content Producer

European Pharmaceutical Review caught up with Destiny Pharma’s CEO, Dr Love, for an exclusive interview to discuss why the pharmaceutical industry needs to radically change its approach to antibiotics in order to combat the threat of bacterial resistance…


Alliance to Save our Antibiotics: antimicrobial resistance ‘to kill one person every 3 seconds by 2050’

Posted on: 13 September 2016 | Author: Niamh Louise Marriott, Digital Content Producer

Following an article about the worrying presence of E.coli in UK supermarkets, our sister title New Food caught up with Emma Rose from Alliance to Save Our Antibiotics for an exclusive interview discussing the latest issues facing antibiotic resistance…


Alzheimer’s disease: reviewing the immediate treatment horizon

Posted on: 5 September 2016 | Author: Stuart Goodman, Blue Latitude Health

Blue Latitude Health's Stuart Goodman discusses the latest progress in Alzheimer's disease research and treatment to find out why a cure remains elusive...

cancer drugs

Re-evaluating the Cancer Drugs Fund: Out with the old, in with the new

Posted on: 31 August 2016 | Author: Niamh Louise Marriott, Digital Content Producer

In April of this year, NICE started to assess the cost and clinical effectiveness of every drug currently in the old cancer drugs fund...

Hepatitis C

Hepatitis C: commitment to a cure

Posted on: 28 July 2016 | Author: Niamh Louise Marriott, Digital Content Producer

To find out more about Hepititis C, European Pharmaceutical Review spoke with Raquel Peck, CEO of the World Hepatitis Alliance and discovered exactly what it is being done to combat this widespread global health issue...


Celltrion Healthcare on Remsima and biosimilars

Posted on: 15 July 2016 | Author: European Pharmaceutical Review

With Remsima being on the market for a year, European Pharmaceutical Review caught up with Celltrion Healthcare to find out more about biosimilars...

cystic fibrosis

Exploring the need for mutation-specific treatments in cystic fibrosis

Posted on: 1 July 2016 | Author: Caroline Richards, Editor, European Pharmaceutical Review

Here, Caroline Richards, Editor of European Pharmaceutical Review, discusses cystic fibrosis and the treatment options that are currently available or in development...

eu referendum

EU Referendum: Tell us what you think…

Posted on: 20 June 2016 | Author: Caroline Richards, Editor, European Pharmaceutical Review

With only days to go until Britain holds a referendum on its EU membership, we can't help but wonder how you feel...


Growth remedy: Accelerating drug performance by prioritising patient opportunities

Posted on: 13 June 2016 | Author: Joaquim Nascimento

In this article, Joaquim Nascimento discusses a three-step process to identify and prioritise initiatives to improve drug sales...

eu referendum

Leaving EU could be a setback for Life Sciences in the UK

Posted on: 8 June 2016 | Author: Dr Alexander Moscho, Bayer UK & Ireland CEO

In this opinion piece, Dr Alexander Moscho, Bayer UK & Ireland CEO, says a vote to leave the EU will deter investment and make it harder for patients to access new medicines...

boehringer ingelheim

Boehringer Ingelheim at ASCO: Oncology and Innovation

Posted on: 6 June 2016 | Author: Victoria White, Digital Content Producer

We recently caught up with Dr Jörg Barth, Boehringer Ingelheim, to find out more about the company’s oncology pipeline and presence at ASCO....


Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +